NASDAQ trade advice (A): US biotechnology stock | 5-6% gain | USA stock trading signal on 30 Jun 2026

Date
June 30, 2026
Analysed By
Naranj Capital Research Desk
Stock Market
NASDAQ, United States of America

Stock Trading Signals in USA

  • Buy
  • Buy
    Range
  • Target
  • Stoploss
  • Upside
    Potential
  • Trade
    Duration
  • Nurix Therapeutics
  • 23.4 - 23.7
  • 25 - 25.2
  • Below 21.7
  • 5% – 6%
  • 12 - 14 Days
  • Locked Image
    Locked Image
    Locked Image
    Locked Image

    5% – 6%

    12 - 14 Days

  • Buy
    Nurix Therapeutics
  • Buy
    Range
    23.4 - 23.7
  • Target
    25 - 25.2
  • Stoploss
    Below 21.7
  • Upside
    Potential
    5% – 6%
  • Trade
    Duration
    12 - 14 Days
  • Locked Image
    Locked Image
    Locked Image
    Locked Image

    5% – 6%

    12 - 14 Days

    * Once the first target hit, reset the StopLoss at your buying price.

    Nurix Therapeutics (NASDAQ: NRIX) - Stock Overview

  • NASDAQ Code
  • Stock Name
  • Sector
  • 52 Weeks High
  • 52 Weeks Low
  • NRIX
  • Nurix Therapeutics
  • Biotechnology
  • 24.03
  • 8.20
  • NASDAQ Code NRIX
  • Stock Name Nurix Therapeutics
  • Sector Biotechnology
  • 52 Weeks High 24.03
  • 52 Weeks Low 8.20
  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) - Technical Analysis (Daily)

    Flex - Daily Technical Analysis
    Flex - Daily Technical Analysis

    • The stock witnessed a significant drop from its peak before stabilizing near the 26 level.
    • A strong bounce from this support, reinforced by a breakout from the Pole & Flag pattern, suggests a bullish continuation may be underway.
  • Flex (NASDAQ: FLEX) - RSI Indicator

    Flex stock analysis based on RSI Indicator
    Flex - RSI Indicator

    • Current RSI of this stock is 71.74, which indicates the strength of buyers.

  • Flex (NASDAQ: FLEX) - ADX & DI Indicator

    Flex stock analysis based on ADX & DI Indicator
    Flex - ADX & DI Indicator

    • Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.

  • Conclusion - Flex (NASDAQ: FLEX) Stock Price Forecast

    Based on our swing stock trading tips in USA stocks, Flex stock price target will be USD 45 - USD 45.5 in the next 12-14 trading sessions.

  • Share with
    0 0 votes
    Article Rating
    Subscribe
    Notify of
    guest
    0 Comments
    Join Our Telegram Channel for Saudi Stock Market Update
    Saudi Stock Analysis
    Join Our Telegram Channel for USA Stock Analysis Update
  • Buy
  • Buy
    Range
  • Target
  • Stoploss
  • Upside
    Potential
  • Trade
    Duration
  • Nurix Therapeutics
  • 23.4 - 23.7
  • 25 - 25.2
  • Below 21.7
  • 5% – 6%
  • 12 - 14 Days
  • Buy Nurix Therapeutics
  • Buy
    Range
    23.4 - 23.7
  • Target 25 - 25.2
  • Stoploss Below 21.7
  • Upside
    Potential
    5% – 6%
  • Trade
    Duration
    12 - 14 Days
  • Buy
  • Buy
    Range
  • Target
  • Stoploss
  • Upside
    Potential
  • Trade
    Duration
  • Nurix Therapeutics
  • 23.4 - 23.7
  • 25 - 25.2
  • Below 21.7
  • 5% – 6%
  • 12 - 14 Days
  • Locked Image
    Locked Image
    Locked Image
    Locked Image

    5% – 6%

    12 - 14 Days

  • Buy
    Nurix Therapeutics
  • Buy
    Range
    23.4 - 23.7
  • Target
    25 - 25.2
  • Stoploss
    Below 21.7
  • Upside
    Potential
    5% – 6%
  • Trade
    Duration
    12 - 14 Days
  • Locked Image
    Locked Image
    Locked Image
    Locked Image

    5% – 6%

    12 - 14 Days

    * Once the first target hit, reset the StopLoss at your buying price.
    * Trade durations are approximate; actual holding period may vary.

    Nurix Therapeutics (NASDAQ: NRIX) - Stock Overview

  • NASDAQ Code
  • Stock Name
  • Sector
  • 52 Weeks High
  • 52 Weeks Low
  • NRIX
  • Nurix Therapeutics
  • Biotechnology
  • 24.03
  • 8.20
  • NASDAQ Code NRIX
  • Stock Name Nurix Therapeutics
  • Sector Biotechnology
  • 52 Weeks High 24.03
  • 52 Weeks Low 8.20
  • Company profile

    Nurix Therapeutics, founded in 2009 and headquartered in Brisbane, California, is a clinical-stage biopharmaceutical company developing targeted cancer and immune disease therapies using protein degradation technology. Its pipeline includes experimental treatments for blood cancers, autoimmune disorders, and inflammatory diseases, supported by strategic partnerships with Gilead Sciences, Sanofi, and Pfizer.

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) vs NASDAQ - Relative Strength Comparison

    The image showcases Flex's 1-year performance relative to NASDAQ.
    Relative Performance - Last 1 Year
    FLEX —   NASDAQ —

  • Flex (NASDAQ: FLEX) - Technical Analysis (Daily)

    Flex - Daily Technical Analysis
    Flex - Daily Technical Analysis

    • The stock witnessed a significant drop from its peak before stabilizing near the 26 level.
    • A strong bounce from this support, reinforced by a breakout from the Pole & Flag pattern, suggests a bullish continuation may be underway.
  • Flex (NASDAQ: FLEX) - RSI Indicator

    Flex stock analysis based on RSI Indicator
    Flex - RSI Indicator

    • Current RSI of this stock is 71.74, which indicates the strength of buyers.

  • Flex (NASDAQ: FLEX) - ADX & DI Indicator

    Flex stock analysis based on ADX & DI Indicator
    Flex - ADX & DI Indicator

    • Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.

  • Conclusion - Flex (NASDAQ: FLEX) Stock Price Forecast

    Based on our swing stock trading tips in USA stocks, Flex stock price target will be USD 45 - USD 45.5 in the next 12-14 trading sessions.

  • Share with
    0 0 votes
    Article Rating
    Subscribe
    Notify of
    guest
    0 Comments

    Join Our Telegram Channel for USA Stock Market Update

    USA Stock Analysis

    Details of Arijit Banerjee

    Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.

    Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.

    Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.

    If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website